Iprs Pharmachem (Opc) Private Limited
Founded in 2020 and headquartered in Telangana, India.
2020 | Hyderabad, Telangana (India) | Active
Iprs Pharmachem (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -31.98%
- Profit Growth -70.24%
- Ebitda -67.47%
- Net Worth 20.81%
- Total Assets -30.89%
About Iprs Pharmachem (Opc)
Iprs Pharmachem (Opc) Private Limited (IPOPL) is a Company incorporated in India on 03 June 2020 (Four years and eight months 25 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeswaridevi Puli serves as a director at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397TG2020OPC140595
- Company No.
140595
- Incorporation Date
03 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Home Appliances
Pharmaceuticals
Who are the key members and board of directors at Iprs Pharmachem (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeswaridevi Puli  | Director | 28-Jul-2021 | Current |
Financial Performance of Iprs Pharmachem (Opc).
Iprs Pharmachem (Opc) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 31.98% decrease. The company also saw a substantial fall in profitability, with a 70.24% decrease in profit. The company's net worth Soared by an impressive increase of 20.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iprs Pharmachem (Opc)?
Unlock access to Iprs Pharmachem (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Iprs Pharmachem (Opc)?
Iprs Pharmachem (Opc) has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iprs Pharmachem (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iprs Pharmachem (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
